The 13th European Conference on Clinical Neuroimaging (ECCN) brought together physicians and researchers from all brain imaging modalities (from PET to SPECT and MRI) and also provided a window into other innovative biomarkers, new technologies and emerging areas of clinical neuroimaging. The conference was held in Madrid, Spain from March 24th-26th, 2025.

On Tuesday 25 March, an AMYPAD satellite symposium sponsored by Life Molecular Imaging took place:

Title: “What does AMYPAD study reveal about centiloid relevance for the future clinical setting?”

•  5’ Introduction – Esther Pérez Martínez
• 15’ Clinical value of AMYPAD study – Pierre Payoux
• 15’ Centiloid recommendations for clinical context-of-use in challenging cases – Lyduine Collij
• 10’ Questions & discussion

You can find more information about the conference here: https://www.euroccn.com/